Aleglitazar, a new, potent, and balanced dual PPARalpha/gamma agonist for the treatment of type II diabetes.
Bioorg Med Chem Lett
; 19(9): 2468-73, 2009 May 01.
Article
in En
| MEDLINE
| ID: mdl-19349176
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oxazoles
/
Thiophenes
/
PPAR alpha
/
PPAR gamma
/
Diabetes Mellitus, Type 2
Limits:
Animals
/
Humans
Language:
En
Journal:
Bioorg Med Chem Lett
Journal subject:
BIOQUIMICA
/
QUIMICA
Year:
2009
Document type:
Article
Affiliation country:
Switzerland
Country of publication:
United kingdom